FDA clears Scopio Labs digital cell morphology platform
Scopio Labs received FDA 510(k) clearance for its X100HT hematology digital cell morphology platform with peripheral blood smear review.
Link to full article
In the media
Back to news lobby
February 25, 2026
Scopio Labs Achieves EU IVDR Certification for AI-Powered Full-Field Digital Morphology Platforms
PARSIPPANY, N.J. — February 25, 2026 – Scopio Labs today announced it has achieved IVDR certification from BSI, a major regulatory milestone that clears the path for its AI-driven digital morphology...
Read more
July 31, 2025
First Of Its Kind Ai Powered Solution Fully Automates Blood Morphology
Scopio unveiled its groundbreaking Complete Blood Morphology (CBM) analyzer, bringing unprecedented scale, efficiency, and standardization to hematology.
Link to full article
July 27, 2025
Scopio Labs Unveils First-of-Its-Kind AI-Powered Solution to Fully Automate Blood Morphology
Scopio’s Complete Blood Morphology (CBM®) ushers in a new era of lab automation, analyzing 10x more cells than the current standard of care in blood cell morphology, addressing global laboratory staffing...
Read more
